The adjuvanted influenza vaccines with novel adjuvants: Experience with the MF59-adjuvanted vaccine

Vaccine

Volumn 19, Issue 17-19, 2001, Pages 2673-2680

  Podda, Audino ^a  

^a CHIRON VACCINES   (Italy)

Author keywords

Adjuvanted vaccines; Influenza vaccine

Indexed keywords

IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; VIRUS ANTIBODY; VIRUS ANTIGEN;

ADJUVANT CHEMOTHERAPY; ANTIBODY TITER; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEVER; HEADACHE; HUMAN; IMMUNOGENICITY; IMMUNOSTIMULATION; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MALAISE; META ANALYSIS; MYALGIA; PAIN; PRIORITY JOURNAL; SEROCONVERSION; SKIN IRRITATION; VIRUS STRAIN;

ADJUVANTS, IMMUNOLOGIC; AGED; ANTIBODIES, VIRAL; DATABASES, FACTUAL; EMULSIONS; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ITALY; MALE; POLYSORBATES; SAFETY; SQUALENE;

EID: 0035925666     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00499-0     Document Type: Conference Paper

References (21)

1. Clinical manifestations and consequences of influenza
2. Impact of Influenza epidemics on mortality in the United States from October 1972 to May 1985
3. Prevention and control of influenza
4. Prevention of respiratory infections in adults: Influenza and pneumoccocal vaccines
5. Influenza in the elderly: Report of an outbreak and review of vaccine effectiveness reports
6. The efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature
7. Failure of influenza vaccination in the aged
8. Failure to respond to influenza vaccine in the aged: Correlation with B-cell number and function
9. Safety and immunogenicity of a 45-microgram supplemental dose of inactivated split-virus influenza B vaccine in the elderly
10. Effectiveness of inactivated influenza vaccine among non-institutionalised elderly persons
11. Inactivated influenza vaccines
12. New and improved vaccines against influenza
13. Adjuvants for human vaccines - Current status, problems and future prospects
14. Dendritic cells internalize vaccine adjuvant after intramuscular injection
15. The adjuvant MF59: A 10-year perspective
16. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59
17. MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice
18. Development of an adjuvant to enhance the immune response to influenza vaccine in the elderly
19. Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons
20. Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly
21. Protection against influenza after annually repeated: A meta-analysis of serologic and field studies